ATLAS Molecular Pharma has been awarded with one of the prestigious NEOTEC grants (2016 call)

2017-03-07T19:47:38+00:00March 14th, 2017|News|

ATLAS Molecular Pharma succeeded with the competitive NEOTEC call (CDTI), obtaining a grant for a total amount of 213.000 EUR during the period 2017-2018. The NEOTEC Program aims to support the creation and consolidation of technology-based companies and it takes into account the creation of new technology and the innovation character of the business initiative.